The Next Big Thing:...
Health Care: Health Services
Antares Pharma Inc. (AIS: AMEX)
$2.68 -0.03 | -1.11%
02/09/12 - 04:00 PM ET
1.31M / 1.60M
Vol / Avg. Vol:2.76 / 2.71
Open / Prev. Close:2.67 - 2.79
Today's Range:1.50 - 2.88
52 Wk Range:23.18%
Performance YTD:TheStreet Rating:
Portfolios with AIS
- Portfolio NameUser Type
- Contributor5 Stocks Under-$10 Setting ...
- UserSMITTY
- Contributor8 Health Care Stocks With R...
- ContributorBreakout Stocks Of The Week...
- UserCurrent
- Userparvardigar
- Userhpats Portfolio 1
- Contributor11 Penny Stocks to Sell Now
- Userphospho
- UserTraderO4000 Portfolio 1
Latest AIS Headlines from TheStreet
- Biotech Stock Live Chat: 2012 Preview 12.15.11 | 11:12 am
- Antares Stock Gaps Down On Today's Open (AIS) 12.15.11 | 09:12 am
- BioSante Pharma Readying Release of 'Female Viagra' Study Results 12.14.11 | 12:12 pm
- 5 Stocks Under $10 With Big Upside Potential 11.18.11 | 06:11 am
- 8 Health Care Stocks With Recent Gains 06.29.11 | 02:06 pm
- 4 Stocks Setting Up to Break Out 06.10.11 | 03:06 pm
- 11 Penny Stocks to Sell Now 07.20.10 | 11:07 am
- Hot Penny Stocks to Buy 06.14.10 | 11:06 am
- Pluristem Therapeutics, Compugen: Early Volume Plays 03.02.10 | 09:03 am
- Midday Movers: Pump Up the Volume 10.16.09 | 02:10 pm
Press Releases for AIS
- Antares Pharma Enters Licensing Agreement With Daewoong Pharmaceuticals Co. Ltd. For Oxybutynin Gel 3% In South Korea - Business Wire 01.17.12 | 08:01 am
- Antares Pharma Enters Licensing Agreement With Pfizer Consumer Healthcare - Business Wire 12.20.11 | 09:12 am
- Antares Pharma To Present At The Oppenheimer 22nd Annual Healthcare Conference - Business Wire 12.12.11 | 10:12 am
- Antares' Oxybutynin Gel Product Approved By FDA For The Treatment Of Overactive Bladder - PR Newswire 12.08.11 | 07:12 am
- Antares Pharma Announces Issuance Of New U.S. Patent Covering LibiGel® - Business Wire 11.29.11 | 08:11 am
- Antares Pharma Reports Third Quarter 2011 Financial And Operating Results - Business Wire 11.08.11 | 04:11 pm
- Antares Pharma To Host Third Quarter 2011 Earnings Call - Business Wire 11.01.11 | 09:11 am
- Antares Pharma Granted New U.S. Patent Covering VIBEX™ Injector Technology - Business Wire 10.04.11 | 09:10 am
- Antares Pharma Reports Second Quarter 2011 Financial And Operating Results - Business Wire 08.08.11 | 04:08 pm
- Antares Pharma Announces Positive Study Results With VIBEX™ MTX In Rheumatoid Arthritis Patients - Business Wire 08.04.11 | 09:08 am
Partner Headlines for AIS
- SIGA Could Be Ready For A Large Short-Term Pop - Seeking Alpha 01.15.12 | 09:01 am
- Antares Pharma's New Blockbuster Drug Has Potential To Generate Long-Term Revenue - Seeking Alpha 12.28.11 | 06:12 am
- Watson-Amgen to Develop Biosimilars - Analyst Blog - Zacks 12.20.11 | 10:12 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Antares In A Very Enviable Takeover Position - Seeking Alpha 11.18.11 | 07:11 am
- If Europe Gets Worse, Stay Away From These 13 U.S. Stocks - Seeking Alpha 11.11.11 | 04:11 pm
- 20 Smart Money Stock Picks Trading Under $5 - Seeking Alpha 11.03.11 | 07:11 am
- Due Diligence And Speculative Biotech Investing - Seeking Alpha 09.27.11 | 08:09 am
- Using Celgene Option Income To Speculate On Biotech - Seeking Alpha 09.13.11 | 08:09 am
- Add Questcor To Your Diversified High-Growth Biotech Portfolio - Seeking Alpha 08.28.11 | 06:08 am
